Abirateron Alpha-Medical 500 mg filmom obložene tablete
| Name | Abirateron Alpha-Medical 500 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-100754760 |
| Active Substance | abirateronacetat |
| Composition | svaka tableta sadrži 500 mg abirateronacetata |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 56 tableta u blisteru, u kutiji [HR-H-100754760-01] 60 tableta u blisteru, u kutiji [HR-H-100754760-02] 56 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-100754760-03] 60 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-100754760-04] 60 tableta u bočici, u kutiji [HR-H-100754760-05] |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska
Synthon BV, Nijmegen, Nizozemska |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 03.05.2021 |
| MA Period of Validity | 03.05.2026 |
| Classification Number | UP/I-530-09/19-01/186 |
| Registration Number | 381-12-01/154-21-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02BX03 |
| Medicinal product marketed in the Croatia | Nestašica |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
